LIVONIA, Mich., March 10, 2022 /PRNewswire/ — nanoMAG® LLC, a medical device company that has developed a bioabsorbable magnesium alloy for use in a wide range of medical implants, is pleased to announce the appointment of Tony Melkent as Vice President, Product Development and Quality.
Tony has over 25 years of experience in the orthopedic and spine markets, both in product development and marketing. He has held leadership positions at Smith & Nephew, Wright Medical and Medtronic. He has spent most of his career at Medtronic leading the commercialization of dozens of market-leading spine products and holds more than 140 U.S. and foreign patents. He received his Bachelor of Science in Mechanical Engineering from the University of Memphis and his MBA from Christian Brothers University.
Tony Melkent said “nanoMAG has a breakthrough material that will bring a significant disruptive change to current methods used to treat orthopedic injuries. Current orthopedic implants are made from metals such as stainless steel or titanium or absorbable polymers such as PLLA or PLGA.nanoMAG has a better solution: biocompatible, bioabsorbable BioMg® magnesium alloy implants that are strong enough to support bone during healing while safely breaking down evenly over time and providing essential minerals which can promote bone regrowth.
Steve LeBeaunanoMAG’s President said, “nanoMAG is delighted to have Tony add his years of medical device product development experience to our leadership team. Tony will lead efforts to conduct an NIH-sponsored preclinical study that will support a device exemption submission to the FDA for craniomaxillofacial (CMF) repairs. nanoMAG will conduct a clinical study on this new class of materials to support our 510(k) commercial approval of Novo and the introduction of devices based on this innovative material to market.”
About nanoMAG, LLC
nanoMAG LLC is a medical device manufacturer and biomaterials company focused on commercializing its patented bioabsorbable magnesium alloy BioMg® for craniomaxillofacial, orthopedic, spine, sports medicine, dental and other biomedical applications where secondary surgeries can be eliminated. The initial focus is on the CMF market which has the highest adoption rate of bioabsorbable polymers and high failure rates for these devices made from polymers. Other areas of use for dental, spinal and vascular access are being developed in collaboration with commercial partners and leading academic medical research centers.
For more information, visit nanoMAG online at https://www.nanomag.us.
Steve LeBeau [email protected]
SOURCE nanoMAG LLC